AstraZeneca: European Commission Approves Forxiga In Treatment Of Symptomatic Chronic Heart Failure

AstraZeneca (AZN,AZN.L) announced Forxiga has been approved in the European Union to extend the indication for heart failure with reduced ejection fraction to cover patients across the full spectrum of left ventricular ejection fraction, including heart failure with mildly reduced and preserved ejection fraction. The approval was based on the positive results from the DELIVER Phase III trial1.

Forxiga is approved for the treatment of patients with type-2 diabetes, HFrEF and CKD in more than 100 countries. The heart failure indication extension application is currently under review in the US and other countries.

For More Such Health News, visit rttnews.com.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The chairman of Saudi National Bank, Ammar Al Khudairy, has resigned days after he commented about Credit Suisse Group AG that allegedly sent the Swiss bank's stock into a tailspin, ending in its subsequent takeover by domestic rival UBS Group. In a statement, Saudi National Bank or SNB, Credit Suisse's largest shareholder, said it has appointed Chief Executive Officer Saeed Mohammed Al Ghamdi... Kansas -based Elkhorn Valley Packing has recalled around 3,436 pounds of boneless beef chuck product citing possible E. coli O103 contamination, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS said. The recall involves various weights corrugated boxes containing "Elkhorn Valley Pride Angus Beef 61226 BEEF CHUCK 2PC BNLS; Packed on 2/16/23." The Federal Deposit Insurance Corp. or FDIC announced an agreement, underwhich First-Citizens Bank & Trust Co., affiliated to First Citizens BancShares, Inc., will buy all deposits and loans of Silicon Valley Bridge Bank, N. A. out of FDIC receivership. The FDIC has been Silicon Valley Bank's receiver after it was collapsed and closed by the New York State Department of Financial Services.
Follow RTT